Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38552056)

  • 1. Mechanistic insights into FEN1-mediated drug sensitivity and risk signature in colon cancer: An integrative bioinformatics study.
    Rao C; Tong J; Yang Y
    Medicine (Baltimore); 2024 Mar; 103(13):e37517. PubMed ID: 38552056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flap endonuclease 1 (FEN1) as a novel diagnostic and prognostic biomarker for gastric cancer.
    Zhao E; Zhou C; Chen S
    Clin Res Hepatol Gastroenterol; 2021 Jan; 45(1):101455. PubMed ID: 32505732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing a prognosis and chemotherapy evaluating model for colon adenocarcinoma based on mitotic catastrophe-related genes.
    Liu Y; Zhao Y; Zhang S; Rong S; He S; Hua L; Wang X; Chen H
    Sci Rep; 2024 Jan; 14(1):1655. PubMed ID: 38238555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of FEN1 Is Associated with the Tumor Progression and Prognosis of Hepatocellular Carcinoma.
    Zhang Y; Liu X; Liu L; Chen J; Hu Q; Shen S; Zhou Y; Chen S; Xue C; Cui G; Yu Z
    Dis Markers; 2020; 2020():2514090. PubMed ID: 32399086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen receptor knockdown enhances prostate cancer chemosensitivity by down-regulating FEN1 through the ERK/ELK1 signalling pathway.
    Xie W; Li S; Guo H; Zhang J; Tu M; Wang R; Lin B; Wu Y; Wang X
    Cancer Med; 2023 Jul; 12(14):15317-15336. PubMed ID: 37326412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of Flap Endonuclease 1 Correlates with Enhanced Proliferation and Poor Prognosis of Non-Small-Cell Lung Cancer.
    Zhang K; Keymeulen S; Nelson R; Tong TR; Yuan YC; Yun X; Liu Z; Lopez J; Raz DJ; Kim JY
    Am J Pathol; 2018 Jan; 188(1):242-251. PubMed ID: 29037854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological and clinical significance of flap endonuclease‑1 in triple‑negative breast cancer: Support of metastasis and a poor prognosis.
    Xu L; Qu JL; Song N; Zhang LY; Zeng X; Che XF; Hou KZ; Shi S; Feng ZY; Qu XJ; Liu YP; Teng YE
    Oncol Rep; 2020 Dec; 44(6):2443-2454. PubMed ID: 33125141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of human flap endonuclease 1 (FEN1) inhibitors using a machine learning based consensus virtual screening.
    Deshmukh AL; Chandra S; Singh DK; Siddiqi MI; Banerjee D
    Mol Biosyst; 2017 Jul; 13(8):1630-1639. PubMed ID: 28685785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low expression of bestrophin-2 is associated with poor prognosis in colon cancer.
    Wang L; Zhu H; Sun W; Liang L; Li H; Han C; Huang W; Zhao B; Peng P; Qin M; Shi L; Mo Y; Huang J
    Gene; 2022 Mar; 813():146117. PubMed ID: 34902511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGFβ1- miR-140-5p axis mediated up-regulation of Flap Endonuclease 1 promotes epithelial-mesenchymal transition in hepatocellular carcinoma.
    Li C; Zhou D; Hong H; Yang S; Zhang L; Li S; Hu P; Ren H; Mei Z; Tang H
    Aging (Albany NY); 2019 Aug; 11(15):5593-5612. PubMed ID: 31402791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YY1 suppresses FEN1 over-expression and drug resistance in breast cancer.
    Wang J; Zhou L; Li Z; Zhang T; Liu W; Liu Z; Yuan YC; Su F; Xu L; Wang Y; Zhou X; Xu H; Hua Y; Wang YJ; Zheng L; Teng YE; Shen B
    BMC Cancer; 2015 Feb; 15():50. PubMed ID: 25885449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flap endonuclease 1 is a promising candidate biomarker in gastric cancer and is involved in cell proliferation and apoptosis.
    Wang K; Xie C; Chen D
    Int J Mol Med; 2014 May; 33(5):1268-74. PubMed ID: 24590400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Activated Dendritic-Cell-Related Gene Signature Indicative of Disease Prognosis and Chemotherapy and Immunotherapy Response in Colon Cancer Patients.
    Ouyang Y; Yu M; Liu T; Suo M; Qiao J; Wang L; Li N
    Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and validation of a seven-gene prognostic marker in colon cancer based on single-cell transcriptome analysis.
    Zhou Y; Guo Y; Wang Y
    IET Syst Biol; 2022 Apr; 16(2):72-83. PubMed ID: 35352485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a Tumor Microenvironment-Related Gene Signature Indicative of Disease Prognosis and Treatment Response in Colon Cancer.
    Chen W; Huang J; Xiong J; Fu P; Chen C; Liu Y; Li Z; Jie Z; Cao Y
    Oxid Med Cell Longev; 2021; 2021():6290261. PubMed ID: 34497681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose metabolism-based signature predicts prognosis and immunotherapy strategies for colon adenocarcinoma.
    Bai Z; Yan C; Nie Y; Zeng Q; Xu L; Wang S; Chang D
    J Gene Med; 2024 Jan; 26(1):e3620. PubMed ID: 37973153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptome Analysis of FEN1 Knockdown HEK293T Cell Strain Reveals Alteration in Nucleic Acid Metabolism, Virus Infection, Cell Morphogenesis and Cancer Development.
    Liu SB; Qiu XQ; Guo WQ; Li JL; Su Q; Du JH; Hu HJ; Wang XX; Song YH; Lou X; Xu XB
    Comb Chem High Throughput Screen; 2019; 22(6):379-386. PubMed ID: 31272350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Jianpi-yangwei decoction inhibits DNA damage repair in the drug resistance of gastric cancer by reducing FEN1 expression.
    Huang W; Tang H; Wen F; Lu X; Li Q; Shu P
    BMC Complement Med Ther; 2020 Jun; 20(1):196. PubMed ID: 32586310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer.
    Abdel-Fatah TM; Russell R; Albarakati N; Maloney DJ; Dorjsuren D; Rueda OM; Moseley P; Mohan V; Sun H; Abbotts R; Mukherjee A; Agarwal D; Illuzzi JL; Jadhav A; Simeonov A; Ball G; Chan S; Caldas C; Ellis IO; Wilson DM; Madhusudan S
    Mol Oncol; 2014 Oct; 8(7):1326-38. PubMed ID: 24880630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flap endonuclease 1 Facilitated Hepatocellular Carcinoma Progression by Enhancing USP7/MDM2-mediated P53 Inactivation.
    Bian S; Ni W; Zhu M; Zhang X; Qiang Y; Zhang J; Ni Z; Shen Y; Qiu S; Song Q; Xiao M; Zheng W
    Int J Biol Sci; 2022; 18(3):1022-1038. PubMed ID: 35173534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.